BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 19414676)

  • 1. Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis.
    Tomida S; Takeuchi T; Shimada Y; Arima C; Matsuo K; Mitsudomi T; Yatabe Y; Takahashi T
    J Clin Oncol; 2009 Jun; 27(17):2793-9. PubMed ID: 19414676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancer.
    Roepman P; Jassem J; Smit EF; Muley T; Niklinski J; van de Velde T; Witteveen AT; Rzyman W; Floore A; Burgers S; Giaccone G; Meister M; Dienemann H; Skrzypski M; Kozlowski M; Mooi WJ; van Zandwijk N
    Clin Cancer Res; 2009 Jan; 15(1):284-90. PubMed ID: 19118056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression signature predicts recurrence in lung adenocarcinoma.
    Larsen JE; Pavey SJ; Passmore LH; Bowman RV; Hayward NK; Fong KM
    Clin Cancer Res; 2007 May; 13(10):2946-54. PubMed ID: 17504995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer.
    Yanagisawa K; Tomida S; Shimada Y; Yatabe Y; Mitsudomi T; Takahashi T
    J Natl Cancer Inst; 2007 Jun; 99(11):858-67. PubMed ID: 17551146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prognostic test for adenocarcinoma of the lung from gene expression profiling data.
    Gordon GJ; Richards WG; Sugarbaker DJ; Jaklitsch MT; Bueno R
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):905-10. PubMed ID: 14504202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung.
    Raponi M; Zhang Y; Yu J; Chen G; Lee G; Taylor JM; Macdonald J; Thomas D; Moskaluk C; Wang Y; Beer DG
    Cancer Res; 2006 Aug; 66(15):7466-72. PubMed ID: 16885343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of clinical outcome in multiple lung cancer cohorts by integrative genomics: implications for chemotherapy selection.
    Broët P; Camilleri-Broët S; Zhang S; Alifano M; Bangarusamy D; Battistella M; Wu Y; Tuefferd M; Régnard JF; Lim E; Tan P; Miller LD
    Cancer Res; 2009 Feb; 69(3):1055-62. PubMed ID: 19176396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiling defines a recurrence signature in lung squamous cell carcinoma.
    Larsen JE; Pavey SJ; Passmore LH; Bowman R; Clarke BE; Hayward NK; Fong KM
    Carcinogenesis; 2007 Mar; 28(3):760-6. PubMed ID: 17082175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profile prospectively predicts peritoneal relapse after curative surgery of gastric cancer.
    Takeno A; Takemasa I; Seno S; Yamasaki M; Motoori M; Miyata H; Nakajima K; Takiguchi S; Fujiwara Y; Nishida T; Okayama T; Matsubara K; Takenaka Y; Matsuda H; Monden M; Mori M; Doki Y
    Ann Surg Oncol; 2010 Apr; 17(4):1033-42. PubMed ID: 20012501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA signature predicts survival and relapse in lung cancer.
    Yu SL; Chen HY; Chang GC; Chen CY; Chen HW; Singh S; Cheng CL; Yu CJ; Lee YC; Chen HS; Su TJ; Chiang CC; Li HN; Hong QS; Su HY; Chen CC; Chen WJ; Liu CC; Chan WK; Chen WJ; Li KC; Chen JJ; Yang PC
    Cancer Cell; 2008 Jan; 13(1):48-57. PubMed ID: 18167339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma.
    Guo L; Ma Y; Ward R; Castranova V; Shi X; Qian Y
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3344-54. PubMed ID: 16740756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression.
    Lee ES; Son DS; Kim SH; Lee J; Jo J; Han J; Kim H; Lee HJ; Choi HY; Jung Y; Park M; Lim YS; Kim K; Shim Y; Kim BC; Lee K; Huh N; Ko C; Park K; Lee JW; Choi YS; Kim J
    Clin Cancer Res; 2008 Nov; 14(22):7397-404. PubMed ID: 19010856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A training-testing approach to the molecular classification of resected non-small cell lung cancer.
    Yamagata N; Shyr Y; Yanagisawa K; Edgerton M; Dang TP; Gonzalez A; Nadaf S; Larsen P; Roberts JR; Nesbitt JC; Jensen R; Levy S; Moore JH; Minna JD; Carbone DP
    Clin Cancer Res; 2003 Oct; 9(13):4695-704. PubMed ID: 14581339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction.
    Endoh H; Tomida S; Yatabe Y; Konishi H; Osada H; Tajima K; Kuwano H; Takahashi T; Mitsudomi T
    J Clin Oncol; 2004 Mar; 22(5):811-9. PubMed ID: 14990636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A molecular signature in superficial bladder carcinoma predicts clinical outcome.
    Dyrskjøt L; Zieger K; Kruhøffer M; Thykjaer T; Jensen JL; Primdahl H; Aziz N; Marcussen N; Møller K; Orntoft TF
    Clin Cancer Res; 2005 Jun; 11(11):4029-36. PubMed ID: 15930337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of gene expression identifies differentially expressed genes and pathways associated with lymphatic dissemination in patients with adenocarcinoma of the esophagus.
    Lagarde SM; Ver Loren van Themaat PE; Moerland PD; Gilhuijs-Pederson LA; Ten Kate FJ; Reitsma PH; van Kampen AH; Zwinderman AH; Baas F; van Lanschot JJ
    Ann Surg Oncol; 2008 Dec; 15(12):3459-70. PubMed ID: 18825457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-gene prognostic classifier for early-stage non small-cell lung cancer.
    Lau SK; Boutros PC; Pintilie M; Blackhall FH; Zhu CQ; Strumpf D; Johnston MR; Darling G; Keshavjee S; Waddell TK; Liu N; Lau D; Penn LZ; Shepherd FA; Jurisica I; Der SD; Tsao MS
    J Clin Oncol; 2007 Dec; 25(35):5562-9. PubMed ID: 18065728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts.
    Hayes DN; Monti S; Parmigiani G; Gilks CB; Naoki K; Bhattacharjee A; Socinski MA; Perou C; Meyerson M
    J Clin Oncol; 2006 Nov; 24(31):5079-90. PubMed ID: 17075127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of the gene expression in non-small cell lung cancer by cDNA array].
    Takada M
    Hokkaido Igaku Zasshi; 2004 Jul; 79(4):427-37. PubMed ID: 15373214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.